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The cholinesterases, acetylcholinesterase (AChE), and butyrylcholinesterase (BChE)
(pseudocholinesterase), are abundant in the nervous system and in other tissues.
The role of AChE in terminating transmitter action in the peripheral and central
nervous system is well understood. However, both knowledge of the function(s) of the
cholinesterases in serum, and of their metabolic and endocrine regulation under normal
and pathological conditions, is limited. This study investigates AChE and BChE in sera
of dystrophin-deficient mdx mutant mice, an animal model for the human Duchenne
muscular dystrophy (DMD) and in control healthy mice. The data show systematic and
differential variations in the concentrations of both enzymes in the sera, and specific
changes dictated by alteration of hormonal balance in both healthy and dystrophic mice.
While AChE in mdx-sera is elevated, BChE is markedly diminished, resulting in an overall
cholinesterase decrease compared to sera of healthy controls. The androgen testosterone
(T) is a negative modulator of BChE, but not of AChE, in male mouse sera. T-removal
elevated both BChE activity and the BChE/AChE ratio in mdx male sera to values
resembling those in healthy control male mice. Mechanisms of regulation of the circulating
cholinesterases and their impairment in the dystrophic mice are suggested, and clinical
implications for diagnosis and treatment are considered.
Keywords: acetylcholinesterase, butyrylcholinesterase, mouse serum, mdx, muscular dystrophy, testosterone,
orchidectomy, H-P-G axis
INTRODUCTION
The presence of cholinesterase activity in serum was already
described by Dale in 1914 (Dale, 1914). It was later found that
this activity was due to the two acetylcholine (ACh)-hydrolyzing
enzymes (Mendel and Rudney, 1943), acetylcholinesterase
(AChE), and butyrylcholinesterase (pseudocholinesterase,
BChE), that could be distinguished by their substrate specificity
(Mendel and Rudney, 1943) and differential sensitivity to selec-
tive inhibitors (Austin and Berry, 1953). By now, both enzymes
have been well-characterized in terms of structure and function
(Massoulié, 2002; Massoulié et al., 2008). AChE is abundant in
the nervous system and muscles, where it is clearly responsible
for controlling the duration of cholinergic transmission (Katz
and Miledi, 1973). Additional functions have been ascribed to
both enzymes in normal development of the nervous system
and in altered physiological or pathological conditions due
to stress, inflammation, and neurodegenerative diseases, (e.g.,
Alzheimer’s disease) and their treatment (for reviews, see e.g.,
Layer and Willbold, 1995; Darvesh et al., 2003, 2010; Ballard
et al., 2005; Dori and Soreq, 2006; Meshorer and Soreq, 2006;
Massoulié et al., 2008; Vogel-Höpker et al., 2012). Moreover,
the soluble form of BChE in mammalian serum may serve as
a safeguard against the diffusion of ACh into the bloodstream
and/or against orally ingested toxic compounds, since it reacts
with a broad range of substrates (Lockridge and Masson, 2000;
Masson and Lockridge, 2010). In fact, serum BChE has been
used as an indicator of hepatic, renal, and thyroid diseases and
as a marker for pesticide toxicity. It is therefore important to
understand how the levels and distribution of the ChEs are
regulated. Such knowledge may have therapeutic consequences
for the treatment of diseases modulated by ChE levels. However,
little attention has been paid to the metabolic, and particularly
to the hormonal, regulation of BChE or of AChE. Several lines of
evidence suggest that such regulation may exist. Thus, rat serum
BChE was shown to be under endocrine regulation by gonadal
steroids and by growth hormone (GH) (Illsley and Lamartiniere,
1981; Lamartiniere, 1986). Furthermore, systematic changes in
AChE/BChE ratios have been established during normal devel-
opment. Thus, whereas AChE activity in rat muscle increased
concomitantly with decrease in BChE, resulting in an inversion
in ratio of the amounts of the two enzymes in adult muscle
(Berman et al., 1987), an opposite change was observed in mouse
serum, leading to a high BChE/AChE ratio post-puberty (Oliver
et al., 1992). However, this was not the case for the serum of
the mdx dystrophin-deficient mutant mouse, an animal model
for Duchenne muscular dystrophy (DMD). In the mdx mouse,
as in DMD patients, a point mutation in the dystrophin gene
results in synthesis of a non-functional truncated protein, so
that full-length dystrophin is absent from skeletal and cardiac
muscles, as well as from certain neural cell populations in the
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brain (Sicinski et al., 1989; for a review see Muntoni et al.,
2003), with devastating, and eventually fatal, consequences in
humans. In mdx sera, AChE activity did not decline with the
onset of puberty as in normal mice sera, but stayed at a high level
(Oliver et al., 1992), which might indicate impaired hormonal
regulation. In the present study we found not only that AChE
activity was elevated but that BChE was drastically diminished
in the mdx sera. We went on to show that in normal mouse
serum BChE levels are subject to endocrine regulation by the
androgen, testosterone (T) in male mice, whereas AChE levels
are not influenced. We further examined whether the systematic
differences in the levels of both ChEs in mdx sera were due to
impaired endocrine regulation, and if hormonal manipulation
can restore the AChE/BChE ratio to that in normal mouse
serum.
MATERIALS AND METHODS
ANIMALS
Male mdx and control (wt) mice from the same mouse strain
(C57BL/10ScSn-Dmdx and C57BL10Sn, Jackson Laboratory, Bar
Harbor,ME)were bred in our animal facility. Animals weremain-
tained and treated according to an approved protocol of the Ethics
Committee (IACUC) of the Hebrew University Medical School.
The Hebrew University is an AAALAC internationally accredited
institute. All mice were maintained under a controlled photope-
riod (lights on 07:00–19:00). Food and water were provided
ad libitum. Body weights were monitored.
SURGICAL MANIPULATIONS
Bilateral orchidectomy
Exteriorized testes and epididymis of 19–21 week mice were
removed under anaesthesia (0.45mg ketamine/0.05mg xylazine
per ml saline solution, 0.9ml/mouse, i.p.). Briefly, the spermatic
cord was clamped with a hemostat. Then, the distal portions
of the vas deferens and spermatic artery were severed. Once
homeostasis had been achieved (∼5min), the spermatic cord
was unclamped, and the incision was closed. All control animals
underwent sham surgery.
Testosterone implants
This procedure was kindly provided by Dr. Robert A. Steiner
(U. Washington, Seattle, WA). Immediately after orchidectomy
(or sham surgery), testosterone capsules (T, 20–25mg/pellet),
were implanted subcutaneously (about halfway down the mouse’s
back) via a small incision at the base of the neck. Then the skin
was sutured and the animal was allowed to wake up. The T pel-
let was designed to achieve normal physiological levels. The dose
was chosen based on previous research, which established that
it would produce significant androgenic actions at target tissues,
i.e., spermatogenesis in gonadotropin-deficient mice (Singh et al.,
1995; Lindzey et al., 1998). All untreated animals received empty
(sham) capsules.
COLLECTION OF BLOOD AND SEPARATION OF PLASMA
Submandibular vein withdrawal for ChE measurements
Blood samples for the measurement of circulating ChE concen-
trations were collected via heparinized capillaries from punctured
submandibular vein of lightly sedated mice (ketamine hydrochlo-
ride/xylazine, ∼0.1ml/mouse, i.p.). Blood was drawn during the
period of 10:00–12:00 am from control and castrated animals of
age ∼21 weeks. It should be noted that prior to blood collec-
tion, all mice were acclimated for 2 weeks under a new controlled
photoperiod (lights on 09:00–21:00).
Orbital sinus withdrawal for creatine kinase measurements
Creatine kinase (CK) levels in circulation were used as a conve-
nient index to confirm the genotype of the animals (see below).
Animals were anesthetized (chloral hydrate solution, 0.05 g/ml,
0.1ml/10 g body weight, i.p.) and 0.5ml of blood was drawn from
the orbital sinus via heparinized capillaries.
Sera
After blood collection, samples were allowed to clot for 30min
at room temperature (RT), and then centrifuged (Eppendorf
5415 at 1250 rpm, 15min, RT). The separated plasma was stored
at −80◦C. Sera from male rhesus macaque were a generous gift
from Dr. Tony Plant (U. Penn., Pittsburgh, PA) and bovine sera
were kindly donated by Dr. Joel Zeron (SION A.I. Center &
Breeding Ltd., Shikmim, Israel).
DETERMINATION OF ChE ACTIVITIES IN SERA
Spectrophotometric method
ChE activity was measured in microplates by the colori-
metric method of Ellman et al. (1961) in 1.0mM 5,5′-
dithio-bis(2-nitrobenzoic acid) (DTNB) in 0.1M Tris, pH 7.6,
containing 0.5mM acetylthiocholine iodide (ATCh) or butyrylth-
iocholine iodide (BTCh) (Sigma, St. Louis, MO). Selective
inhibitors were used to distinguish between AChE and BChE as
described below. The increase in absorbance at 412 nm was fol-
lowed for 12–15min at 31–34◦C using a PowerWavex340 Model
microplate reader (Bio-Tek Instruments, Inc, Winooski, VT).
Activities were expressed as OD units per minute.
Radiometric method
ChE activity was assayed by a radiometric method, monitor-
ing the 3H-acetate generated during acetylcholine hydrolysis
(Johnson and Russell, 1975). This method is of higher sensitivity
than the Ellman’s technique (see above) thus allowing for bet-
ter resolution when measurement of variations in the low AChE
activities of mouse sera was required. Briefly, samples were incu-
bated in 0.1ml of 1mM of 3H-acetylcholine iodide (3H-ACh,
PerkinElmer Life Sciences) in 0.1M NaCl and 0.01M Tris buffer
(pH 7.4). The reaction was stopped as required by addition of
0.1ml 1M chloroacetic acid/0.5M NaOH/2M NaCl, followed by
addition of 4ml scintillation fluid composed of 90% QuickSafe
N (Zinsser Analytic, Frankfurt, Germany) and 10% isoamyl alco-
hol. The reaction product, [3H]-acetate, was extracted into the
organic phase and counted in a Tri-CARB 2900TR liquid scin-
tillation counter (Packard BioScience, Meriden, CT). Selective
inhibitors were used to distinguish AChE and BChE activities
(see below).
Selective ChE inhibitors
Tetra-isopropyl-pyrophosphoramide(0.1mM,iso-OMPA,Sigma)
and 1,5-bis(4-allyldimethylammoniumphenyl)pentan-3-one
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dibromide (0.01mM, BW284c51, BurroughsWellcome Co.) were
used to selectively inhibit BChE and AChE activities, respectively
(Austin and Berry, 1953). Samples were pre-incubated with either
inhibitor for 20min at RT and then assayed for ChE activity in
the presence of the inhibitors using either the colorimetric or
radiometric method.
DETERMINATION OF CREATINE KINASE (CK) ACTIVITY
Circulating CK values, expressed as units of enzyme activity per
liter of serum sample (U/L), were used as an index to identify the
genotype of the animals (mdx or wt). CK values in blood sam-
ples drawn from orbital sinuses were determined using a standard
enzymatic method and an automated clinical analyzer.
STATISTICAL ANALYSES
Data were collected for samples from individual animals in all
experiments. Mean values were obtained by averaging measure-
ments obtained for a group of 4–10 animals for a particular
experimental day (as indicated in each experiment). The signifi-
cance of differences between groups was determined by One-Way
ANOVA (parametric with Tukey’s multiple comparison post-
test) for all groups, or by Kruskal–Wallis (non-parametric) tests,
depending whether or not the data showed normal Gaussian dis-
tribution. Comparison between two groups was by non-paired
t-test with unequal variances (our usual case). All tests were
available in the GraphPad Prism4 (GraphPad Inc.), Statistica10
(StatSoft) and Microsoft Office Excel Professional Software.
The difference between groups was considered significant when
(p < 0.05).
RESULTS
POST-PUBERTAL EFFECTS OF DYSTROPHY ON BODY WEIGHT
Although the mdx mouse was reproductively competent (thus, T
was present and functional), its postnatal growth was hindered
compared to that of normal controls. The mdx mice displayed
lower and more variable body weight compared to the controls,
with the phenomenon being more pronounced in mdx females
than in males (not shown). However, the body weight stabilized
by 11 weeks of age at levels not significantly different from those
of the control mice (Figure 1). The oscillatory shape of the curve
was consistent with the finding that mdx mouse muscles undergo
cycles of degeneration and regeneration until most muscles sta-
bilize by 10 weeks (Settles et al., 1996). The mice we used were
therefore aged 19–22 weeks, at which age their body weights
are stable, and the majority of muscle fibers no longer display
transient degeneration (Karpati et al., 1988).
SERUM ChE ACTIVITIES IN NORMAL AND DYSTROPHIC MICE
Mouse serum contains BChE and AChE, both of which hydrolyze
ATCh. Total ChE activities in sera of male mdx mice were at least
15% (p < 0.01) below those in normal mice sera (Figure 2A),
indicating reduced levels of AChE and/or BChE in the mdx sera.
AChE activity, which was found to be very low in sera of nor-
mal mice, was significantly elevated in the mdx sera (Figure 2A,
detailed below). In contrast, BChE levels, assayed on BTCh, were
found to decrease in male mdx-sera to 64–67% of the levels in
wt sera (Figure 2B, p < 0.002). Similar results were observed
when BChE was assayed on ATCh, with AChE activity being
FIGURE 1 | Postnatal changes in body weight in male mice.
The effect of strain on body weight is shown. Several litters of C57BL/
10J (wt, •) and mdx (◦) male mice were weighed over 3–21 weeks.
Each data point is the mean ± SEM (n = 6–34). The dashed line
at ∼5 weeks marks initiation of puberty in the wt. ∗p < 0.05 between
wt and mdx of the same age, showing that mdx mice gain less
weight than wt during postnatal development but reach normal level
by 11 weeks.
selectively inhibited by BW284c51 (Figure 2A). Since AChE levels
in normal mouse serum are very low, the more sensitive radio-
metric assay was used to confirm the results obtained using the
colorimetric Ellman procedure (Figures 2C andD), showing that
AChE activity in mdx-sera indeed increased by 50–80% over the
level in control wt sera (p < 0.05), confirming an earlier report
(Oliver et al., 1992). BChE activity was shown, also by the radio-
metric assay, to decrease in mdx-sera to 61–76% of wt values
(Figure 2D, p < 0.001). Since BChE is the major ChE form in
mouse serum (>70%), the large drop in BChE was responsible
for the overall reduction in total ChE activity observed in mdx
sera. However, the decrease in BChE levels, taken together with
the increase in AChE levels, in mdx sera (as shown in Figures 2C
and D), reduced the BChE/AChE ratio from 2.3 ± 0.2 in the wt-
sera to 1.3 ± 0.5 inmdx-sera. Similar results were found for adult
female mdx-mice and are summarized elsewhere (Anglister et al.,
2008).
As an internal control, CK levels in sera were measured to
validate the genotype of the animals (mdx compared to wt).
Consistent with the 3–14-fold elevation reported by Glesby et al.
(1988), the male mdx mice used in our studies showed vari-
able, but consistently increased, CK levels in sera, viz., 9.9 ± 1.4
(×103 U/L, mean ± SEM) in mdx mice, compared to 1.3 ± 0.3
in controls (Figure 2E). These differences were highly significant
(p < 0.001).
ENDOCRINE REGULATION OF NORMAL MOUSE SERUM BChE ACTIVITY
To determine whether the abnormal BChE/AChE ratio in mdx
sera is due to hormonal influences, we first investigated regu-
lation by the androgen, T, of ChEs in the sera of adult male
wt mice.
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FIGURE 2 | Circulating ChE activities in wt and mdx mice. ChE activities
in the sera of adult male wt (C57Bl/10J)  and mdx  mice were assayed
by: (A,B) Measurement using the Ellman colorimetric method, with ATCh as
substrate and the selective inhibitors, iso-OMPA, for measurement of AChE
(striped columns), or BW284c51, for measurement of BChE (plain columns)
(A); BChE activity was also measured using BTCh (B); (C,D) The radiometric
method with 3H-ACh as substrate and with iso-OMPA for AChE (C), or with
BW284c51 for BChE (D). (E) CK levels in the sera of wt and mdx mice.
Activity values represent the mean ± SEM, of samples from 6 to 8 mice per
group for ChEs and of 12 animals per group for CK. Activities in mdx sera
differed from wt significantly: The BChE level in mdx sera was reduced
compared to wt (∗p < 0.01 in B and < 0.05 in D), while AChE in mdx sera
was elevated compared with wt (∗p < 0.05 in A,C). As expected, CK levels in
mdx sera were elevated, compared to those in the wt sera (E, ∗p < 0.001).
Sera from orchidectomized 21 week adult male wt mice were
analyzed for ChE activities (Figure 3). Gonadectomy raised BChE
activities in adult male mice serum by 20–37% (p < 0.001),
whether measured on BTCh, or on ACh in the presence of a
selective AChE inhibitor (Figures 3A and B, respectively).
T-replacement in adult wt males, performed concomitantly
with castration, abolished the increase caused by castration,
restoring BChE activity to the levels observed in the sera of
intact males (Figures 3A and B). Thus, a high basal level of
BChE activity is found in the sera of agonadal males (in the
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FIGURE 3 | Effect of orchidectomy and T-replacement appears to be on
BChE, not on AChE. Activities in wt sera of BChE (A,B) and AChE (C)
were determined colorimetrically (A) or radiometrically (B,C) with
appropriate substrates and selective inhibitors as described in the legend to
Figure 2. Values are the mean ± SEM for 6–8 samples per group (sham
group, n = 3). BChE levels in gonadectomized animals (dashed line in A)
differ significantly from those in intact, T-treated and sham animals: Data
were analyzed by One-Way ANOVA, showing statistical significance in
A (p  0.0002) and in B (p  0.0001), with Tukey’s post-hoc revealing
significant differences (∗) between castrated male (cas, shaded column)
and the other three groups: intact male (male) (p < 0.0003), castrated with
T-replacement (cas + T) (p < 0.0002) or sham (p < 0.0002). All other
comparisons showed insignificance (p > 0.05): male compared to cas + T
(p = 0.086), or to sham (p = 0.07), and cas + T compared to sham
(p = 0.92). Similarly, post-hoc test in B showed significant difference
between cas and the other groups: male (p < 0.001), cas + T (p < 0.0004),
and sham (p < 0.001), which were very similar. No significant changes
were observed in AChE activity (C).
Table 1 | Effect of gonadectomy on serum BChE and AChE levels in
adult male wt mice.
wild-type n BChE AChE BChE:AChE
No surgery 5 1830–2350 790–1010 2.3 ± 0.2
Castrate 8 2770–3870 730–1460 3.0 ± 0.1
Castrate + T 5 1570–2550 530–980 2.5 ± 0.2
Sham 3 1660–2130 870–1040 2.1 ± 0.1
The radiometric data presented in this table (in dpm units) are averaged and
presented as histograms in Figures 3B and C.
absence of T), and both endogenous and exogenous androgen
down-regulate the enzyme.
Whereas castration of the male wt markedly raised the BChE
level in the serum, that of AChE (measured with ACh in the
presence of iso-OMPA) did not change significantly (Figure 3C;
p = 0.41). The ranges of values recorded radiometrically, with
ACh and the respective selective inhibitors of BChE and AChE, in
sera of male adult wt mice under the different treatment regimes,
are shown in Table 1. The data show clearly that BChE activities
were increased from a low level (1830–2350 arbitrary assay units)
to a high level (2770–3870 units) after orchidectomy, and reverted
to the base level after T-implant. In contrast, the AChE activities
observed in adult male mice sera fell in a similar range (530–1460
arbitrary units), whether the mice were intact or castrated, with
or without T-implant. These results indicate a specific and selec-
tive negative androgen modulation of BChE, but not of AChE.
Furthermore, the large increase in BChE after castration resulted
in an increased ratio of BChE to AChE activities from 2.3 ± 0.2
in sera of intact wt males to 3.0 ± 0.1 in castrated wt males
(Table 1).
EFFECTS OF ORCHIDECTOMY AND T-REPLACEMENT ON SERUM
BChE LEVELS IN ADULT mdx MICE
We went on to examine whether orchidectomy raises BChE lev-
els also in the sera of mdx mice, and whether, as a consequence,
the high agonadal baseline ChE levels seen in wt mice sera can
be reached. The data presented in Table 2 and Figure 4 reveal
low levels of BChE in the sera of control adult mdx males
(32.2–48.6 assay units). Although levels increase substantially
after gonadectomy (48.7–61.9 assay units), by an average of 35%,
the BChE deficiency observed in untreated mdx mice is sustained
Table 2 | Effect of gonadectomy in elevating serum BChE activity in
normal and dystrophic mice.
wt mdx p
No surgery 56.1–68.2 (8) 32.2–48.6 (5) <0.002
Castrate 68.0–83.3 (6) 48.7–61.9 (4) <0.002
Castrate + T 50.1–62.3 (6) 34.0–46.2 (5) <0.001
Sham 51.6–57.8 (3) 40.8–44.8 (3) <0.006
Activities relate to the same animals and assay conditions as for the data
displayed in Figure 4.
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FIGURE 4 | T-regulation of BChE activity in male mdx sera. BChE
activities were measured colorimetrically with BTCh as substrate in sera of
intact, castrated, castrated with T-replacement, and sham operated wt 
and mdx  mice, (as in Figure 3A). Values, mean ± SEM for samples
taken from 4 to 8 mice per group (sham group, n = 3). ∗p < 0.001 between
BChE levels in castrated wt and in intact, T-treated, and sham mice sera (of
either wt or mdx strains). ∗∗p < 0.05 (detailed in Table 3) between BChE
levels in castrated mdx and in intact, T-treated, and sham mdx mice sera.
#Significant difference between BChE level in mdx and wt in all the
experimental groups (p-values are listed in Table 2). The dashed black and
red lines indicate BChE levels in agonadal and gonadal wt sera,
respectively.
(Figure 4): thus, the agonadal “baseline” level in mdx mice was
significantly below the baseline level in wt agonadal mice (29%,
p < 0.002). It was slightly lower than the level in control wt mice
(14%, p = 0.06) or in sham-operated wt mice. As in wt mice,
T-replacement reversed the effect of orchidectomy on BChE activ-
ity. Thus, after orchidectomy, the BChE in mdx circulation may
almost reach the gonadal baseline level of BChE activity in the
serum of intact male wt mice, but not the agonadal baseline level
in the serum of castrated wt mice.
T-REGULATION OF SERUM AChE ACTIVITIES IN mdx MICE
We went on to examine the effects of orchidectomy and
T-replacement on AChE levels in the sera of mdx mice.
Specifically, we checked whether orchidectomy of mdx mice,
with or without T-implant, affected serum levels of AChE. As
documented in Table 3, the mean AChE activity in the sera of
intact mdx mice was 1260 ± 120 units, as compared to 790 ±
70 units in the castrated mice. Despite the great variability
in AChE levels, castration appears to reduce AChE activity by
>30%, p < 0.02). Interestingly, the mean value for agonadal
mdx mice was not different from that for gonadal wt mice
(p = 0.2).
T-implant into agonadal mdx mice resulted in a mean serum
AChE activity of 930 ± 180, not significantly different from the
value for agonadal mdx mice lacking the T-implant (p = 0.40).
This value is also very similar to the level in the gonadal wt
mice (p = 0.89), but lower than the average value for gonadal
mdx mice, although a statistically significant difference could
not be demonstrated due to the large standard errors within
the two groups, resulting in p = 0.11. Furthermore, the values
obtained for the small group of “sham” mdx mice analyzed,
were intermediate, not being significantly different from either
the values for sera of intact mdx and intact wt mice (p = 0.34
and 0.39, respectively). These limitations prevent us from draw-
ing definite conclusions concerning the effect of orchidectomy
on serum AChE in mdx mice, although orchidectomy decreases
AChE levels. However, the large increase in BChE levels, cou-
pled with the apparent decrease in AChE levels, in the agondal
mdx mice, results in an increase in the BChE/AChE activity
ratio from 1.2 ± 0.5 in the male mdx-sera to 2.5 ± 0.4 after cas-
tration (Table 3), a ratio similar to that in wt-sera (2.3 ± 0.2,
Tables 1 and 3).
SPECIES-SPECIFIC AND DEVELOPMENTAL VARIATIONS IN
CIRCULATING ChEs
Fetal calf serum is known to be a good source of AChE (Ralston
et al., 1985). It occurred to us that bovine serum might serve as
a good system for testing postnatal down-regulation of serum
AChE, and for examining, in parallel, the regulation of BChE,
assuming BChE to be a serum component common to all species.
We therefore compared ChE activities in fetal bovine sera and
in post-pubertal (adult) bull sera. Consistent with the literature,
we observed a high level of AChE activity, >96% of total ChE,
in fetal bovine sera. Interestingly, AChE activity was >10-fold
lower in adult bull sera (Table 4). However, whereas in adult
mouse serum, BChE was the major ChE component, as in several
Table 3 | Changes in BChE and AChE activities in the sera of adult wt and mdx adult male mice before and after orchidectomy, and after
T-implant.
wt mdx
Male Male Castrate Castrate + T Sham
Total ChEs 3700 ± 100∗∗ 3000 ± 90 3340 ± 220 2880 ± 120 2940 ± 270
BChE 2140 ± 90 1440 ± 70 1970 ± 110∗ 1540 ± 130 1350 ± 90
AChE 910 ± 40 1260 ± 120# 790 ± 70 920 ± 140 1070 ± 140
BChE/AChE 2.3 ± 0.2 1.2 ± 0.5 2.5 ± 0.4 1.7 ± 0.3 1.3 ± 0.2
Data shown refer to the same animals as those used in Figure 4.
∗BChE in castrated mdx sera is significantly elevated compared with mdx male (p < 0.02), castrated with T implant (p < 0.05) and sham sera (<0.01).
∗∗BChE in wt male sera is significantly higher than in mdx male (p < 0.001), castrated with T implant (p < 0.006) and sham sera (p < 0.001).
#AChE in mdx male serum is significantly higher than in castrated mdx (p < 0.02) and in wt male sera (p < 0.05).
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Table 4 | Species-specific variations in circulating ChE activities.
Bovine Macaque Mouse
Fetal Adult Rhesus wt (C57BL) mdx
Total ChE (no inhibitor) 5020 470 2240 3500 ± 210 3260 ± 270
BChE (+BW) 190 100 1990 2140 ± 90 1650 ± 220
AChE (+iso-OMPA) 4830 370 250 910 ± 40 1260 ± 130
BuChE/AChE 0.04 0.27 3.9 ± 0.4 2.3 ± 0.2 1.3 ± 0.5
AChE U/mL∗ 1.2–1.7 0.11 0.081 0.24 0.35
All sera were from male animals. ChE activities were determined by radiometric assay with ACh and the respective inhibitors, and presented as units in 125 μL
serum. Macaque and bovine values were obtained from pooled sera of three animals each. The values observed for bovine sera were confirmed by Drs. B. P. Doctor
and H. Saxena (Walter Reed Army Institute of Research, Silver Spring, MD, pers. communication). ∗AChE U/mL values represent activities calculated in enzyme
units (U = μmoles ACh hydrolyzed/min).
other species (Ecobichon and Corneau, 1973; Chatonnet and
Lockridge, 1989), in bovine sera it was the minor ChE compo-
nent, with very low activity (Table 4). Although BChE activity
in fetal and adult bovine sera was similar, its fraction of the
total ChE activity rose from fetal to adult (∼4–25%) due to
the big drop in AChE activity. Because of the striking differ-
ence in ChE composition of mouse and bovine sera, we decided
to examine the ChE composition of the sera of rhesus (RHS)
monkeys, which are closely related to humans and for which
many endocrinological studies have been performed, including
examination of the effects of androgens. As seen in Table 4,
in adult RHS serum, as in mouse serum, BChE is the major
component (89%).
DISCUSSION
In the present study we explored the regulation of serum ChEs
in normal and dystrophic mice. Several findings were made:
(1) While there is more BChE than AChE activity in mouse
serum, as in the sera of several other mammals (reviewed by
Chatonnet and Lockridge, 1989), the value of the BChE/AChE
ratio for the sera of mdx mice is about half of the ratio for
the sera of wt mice; (2) While AChE levels increased slightly
in the mdx sera (Oliver et al., 1992), BChE levels decreased by
>30%, resulting in an overall decrease in ChE activity of ∼20%
in mdx as compared to wt sera; (3) Although orchidectomy ele-
vated levels of BChE activity in the sera of both strains, levels
in mdx sera remained lower than in wt sera; (4) T-replacement
reversed the effect of orchidectomy on BChE activity in both
wt and mdx sera; (5) T-modulation was specific to serum BChE,
not significantly affecting levels of AChE; (6) Orchidectomy did
not increase AChE activities in either strain. These findings are
consistent with involvement of the hypothalamic-hypophysial-
gonadal (H-P-G) axis in the impairment of BChE activity in
mdx sera.
The regulation of mouse serum ChEs, either AChE or BChE,
via the (H-P-G) axis, has not been previously explored. Our
results demonstrate that testosterone (T) down-regulates the
expression of BChE in sera of mice, confirming the early obser-
vations on male rat sera that the total ChE content was reduced
by circulating T (or increased by estrogen in female), not as a
result of a direct interaction of the steroid with the enzyme but
via higher level regulation (Everett and Sawyer, 1946; Sawyer and
Everett, 1946, 1947; Illsley and Lamartiniere, 1981).
HOW CAN T MODULATE LEVELS OF SERUM BChE?
The target of testosterone (or estrogen) that produces modu-
lation of serum BChE levels is not known. It may be in the
hypothalamus, in the pituitary, or perhaps in a target organ that
produces serum BChE, such as the liver (Leeuwin, 1965), together
with pituitary factors. Experiments on hypophysectomized rats
have demonstrated that pituitary mediation is required for both
androgen and estrogen action (Everett and Sawyer, 1946; Illsley
and Lamartiniere, 1981): while sex steroids do modulate ChE
activity from a basal level, either due to suppression by androgen
inmales, or due to stimulation by estrogen in females, their action
is abolished by hypophysectomy. It has also been shown in rats
that hypophysectomy (Illsley and Lamartiniere, 1981; Edwards
and Brimijoin, 1983) or lesion of the arcuate nucleus in the
hypothalamus of males (Lamartiniere, 1986) reduces levels of GH
and increases levels of ChE in the serum. The effects on serum
ChEs were shown to be reversed by exogenous administration of
GH after either type of surgery. Thus, both T and GH appear to
be negative modulators of rat serumBChE inmale rats.Moreover,
they can act synergistically, since their levels are inter-related: the
hypothalamus regulates the release of pituitary hormones (e.g.,
GH) and gonadotropins that, in turn, drive the gonads to produce
T and estrogen, viz., the H-P-G axis. In addition, T itself influ-
ences GH secretion, and GH in turn reduces serum BChE levels;
thus, T can also reinforce down-regulation of BChE via GH.
WHERE CAN T AND GH EXERT THEIR INFLUENCES ON SERUM BChE?
Serum BChE in adults is apparently produced in the liver
(Silver, 1974). Indeed, GH has been shown to modulate sev-
eral sex-differentiated hepatic enzymes, including serum ChE
(Lamartiniere, 1981, 1986). Since hypophysectomy abolishes rat
liver estrogen receptors and GH restores them, GH may also
restore responsiveness of the liver to circulating sex steroids,
and result in androgen or estrogen modulation of serum ChE.
A similar mechanism could apply to GH regulation of other
potential target organ for serum BChE production. In consid-
ering the liver as the source for serum BChE, it should be
taken into account that, the liver secretes BChE monomers and
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dimers (Perelman et al., 1990), not the G4 tetramer which is the
major isoform in serum (Lockridge et al., 1979). Furthermore, we
have preliminary evidence that T, castration, and T-replacement
after castration, alter predominantly the level of G4 BChE in
mouse serum. Thus, it appears that the BChE isoforms pro-
duced/secreted by the liver are not the isoform present in serum
and modulated by the hormones. This unresolved issue, as
well as the influence of T and/or GH on BChE isoforms in
serum, liver, and other tissues need to be revisited and further
investigated.
IS H-P-G AXIS (AND GH) CONTROL OF SERUM BChE IMPAIRED
IN mdx MICE?
It became apparent in this study that the mdx mice, that lacked
dystrophin, had less BChE in their sera (both before and after
orchidectomy), relative to wt controls. Since T and GH have
both been found to be negative modulators of BChE, it is pos-
sible that the intact mdx mice secrete higher levels of T and/or
GH than the wt mice. Consistent with this suggestion, mdx mice
exhibit hypertrophy of somatotroph cells in the pituitary, and
slightly elevated pituitary GH in adult females (Anderson et al.,
1994). The reduced levels of BChE we show in castrated mdx
mice compared to castrated wt are also likely to be due to gender-
specific effects of GH at the hypothalamic-pituitary level, and
not to a direct effect of T, since castration has eliminated T
from the system. Further studies will be needed to determine
whether the perturbation is at the pituitary or hypothalamic
level.
Further correlation of GH levels with dystrophin deficiency
comes from studies on DMD patients that reported mitigation
of the severity of the dystrophy in GH-deficient patients (Zatz
et al., 1981a,b), or after treatment with a GH inhibitor (Zatz et al.,
1986). Another report provided some evidence for an altered
hypothalamic-hypophyseal axis (Zaccaria et al., 1989). This is
consistent with the observation referred to above, of high GH
levels in mdx sera (Anderson et al., 1994). In addition, insulin
growth factor-1 (IGF-1), which is secreted in correlation with
GH, is elevated in mdx plasma (De Luca et al., 1999). Altogether,
dystrophin deficiency is likely to be associated with impaired
H-P-G-regulation.
REMOVAL OF GONADAL CONTROL NORMALIZES THE
BChE/AChE RATIO IN MALE mdx SERA
Consistent with Oliver et al. (1992), it became apparent in this
study that mdx mice had more AChE in their sera (prior to
orchidectomy), than wt controls. Elevated levels of serum AChE
were also reported for dystrophic chickens (Lyles et al., 1980) and
for other animal dystrophies (Skau, 1985), as well as for fetal calf
serum (Ralston et al., 1985). Oliver et al. (1992) proposed that the
increased AChE levels in the sera of the dystrophic mice reflect
increased release of muscle AChE relative to release inwt controls.
Our finding that post-pubertal castration of adultmdxmales nor-
malizes their serum ChE levels by elevating BChE and, perhaps
reducing AChE, and thus normalizing the BChE:AChE ratio, sug-
gests that the mdx sera BChE levels are not just a reflection of
muscle degradation but are under control of the gonads and of the
aforementioned higher centers. Moreover, in addition to T, there
is likely to be an additional factor involved in the impaired down-
regulation of AChE and up-regulation of BChE in mdx sera. This
seems likely since although the BChE level increased after castra-
tion, it did not reach the agonadal wt level, and T-replacement
did not reverse the effect on mdx serum AChE. Before one can
extrapolate from our results in mice to human patients, one
has to prove that gonadal regulation of BChE occurs in higher
primates.
POSTNATAL MATURATION OF SERUM BChE/AChE RATIO
Because, in mdx sera, AChE failed to decrease upon maturation
and BChE was low in the adult, we considered the possibility that
mdx mice are locked in a pre-adult stage and retain some embry-
onic regulatory properties. It was shown in mouse sera that in
the embryo AChE predominates, while in the adult BChE is the
major ChE species (Oliver et al., 1992). Surprisingly, we report
here strong postnatal down-regulation of AChE in bovine serum,
with only small amounts of BChE in both fetal and adult serum
relative to other species (Table 4). However, we found BChE to be
the major ChE component in sera of adult normal wt mice and
rhesus monkeys (Table 4), as has been reported for many animals
(Ecobichon and Corneau, 1973; Chatonnet and Lockridge, 1989).
Indeed, while human 12th week fetal serum may contain 40%
AChE (Hahn et al., 1993), adult human plasma contains >99%
BChE (Brimijoin andHammond, 1988). Higher primates, such as
the rhesus macaque, should provide an appropriatemodel for fur-
ther studies on the regulation of both AChE and BChE in human
serum.
While in the present study we have shown that the AChE
in mouse serum is not regulated by circulating T, it should be
noted as mentioned, that AChE decreased ∼2-fold in the serum
of normal mice, prior to puberty. During that time, a progressive
increase in AChE coincident with a reduction in BChE occurred
in muscle resulting in inversion in the amounts of the two
enzymes in adult muscle (Berman et al., 1987). Thus it may still
be that the decrease in serum AChE and increase in muscle AChE
are due to one or more postnatal triggers, e.g., humoral factor(s)
discharged before the episodic T release at puberty (∼5 weeks). In
this context, it should be noted that BChE precedes AChE expres-
sion in embryonic neural development of birds (Layer, 1991;
Layer and Willbold, 1994) and mammals (Koenigsberger et al.,
1998).
One needs to bear in mind, considering the various roles
attributed to ChEs in development, during normal function
and in pathological conditions, that modulation of their lev-
els may both reflect and influence normal processes or existing
impairments. In the context of the present study, the abnormal
BChE/AChE ratio in the serum of dystrophic mice, as compared
to normal, may be developed as a tool for easy detection of dys-
trophy, provided similar observations are made for DMD or for
other human dystrophies.
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